|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 228.12 USD | +1.51% |
|
-0.33% | -5.29% |
| 04-15 | Baird Adjusts Price Target on ResMed to $254 From $272, Maintains Neutral Rating | MT |
| 04-13 | Mizuho Adjusts Price Target on ResMed to $255 From $300, Maintains Outperform Rating | MT |
28
Listed companies
8
Private companies
86
Insiders
Relation chart of related listed companies: ResMed, Inc.
Active Relations
Past Relations
Related listed companies: ResMed, Inc.
Active Relations
Past Relations
Relationship chart for related private companies: ResMed, Inc.
Active Relations
Past Relations
Related private companies: ResMed, Inc.
Other Consumer Services
Miscellaneous Commercial Services
Medical/Nursing Services
Miscellaneous Commercial Services
Medical Specialties
Investment Trusts/Mutual Funds
Medical Specialties
Active Relations
Past Relations
Connection statistics
Active
Inactive
Listed companies
Private companies
Activities of related companies
| Medical Specialties | 15 |
| Biotechnology | 3 |
| Pharmaceuticals: Major | 3 |
| Miscellaneous Commercial Services | 2 |
| Information Technology Services | 2 |
| Packaged Software | 2 |
| Investment Trusts/Mutual Funds | 1 |
| Medical/Nursing Services | 1 |
| Other Consumer Services | 1 |
| Real Estate Investment Trusts | 1 |
Countries of related companies
| United States | 23 |
| Australia | 9 |
| France | 1 |
| United Kingdom | 1 |
| Malaysia | 1 |
| Sweden | 1 |
- Stock Market
- Equities
- RMD Stock
- Company ResMed, Inc.
- Connections
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition